Occupational toxic encephalopathy due to 1,2-dichloroethane exposure: a case series | Canada Hyperbarics Skip to main content
Case Report Front Pharmacol 2025

Occupational toxic encephalopathy due to 1,2-dichloroethane exposure: a case series

Li T, Hu W, Rong X, Yang P, Du Y, He S, et al. — Front Pharmacol, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers documented five cases of toxic encephalopathy in workers who were poisoned by occupational exposure to the industrial solvent 1,2-dichloroethane.

What They Found

They observed that 1,2-dichloroethane exposure caused neurological damage, including headache, limb convulsions, and coma, often with increased intracranial pressure. MRI scans helped detect extensive cerebral edema and brain abnormalities in these five patients. Treatment strategies included dehydrating agents, glucocorticoids, and hyperbaric oxygen therapy, with mild cases recovering and severe cases sometimes proving fatal.

What This Means for Canadian Patients

For Canadian patients who might be exposed to industrial solvents like 1,2-dichloroethane and develop toxic encephalopathy, this study suggests that hyperbaric oxygen therapy could be a part of their treatment plan. Early diagnosis using MRI and a combination of therapies may improve outcomes for those suffering from this type of poisoning.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This study is a case series of only five patients, which limits the generalizability of its findings to a larger population.

Was this summary helpful?

Study Details

Study Type Case Report
Category Uncategorised
Source Pubmed
PubMed ID 41019989
Year Published 2025
Journal Front Pharmacol

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.